ChristineNing(Chang)Chang-HalpennyMD

Chief Resident in Radiation Oncology

Dr. Chang-Halpenny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7130 N Millbrook Ave
Ste 100
Fresno, CA 93720
Phone+1 559-326-1222

Fax+1 559-326-1230

Kaiser Permanente Southern California (Los Angeles)Residency, Radiation Oncology, 2013 - 2017
Santa Clara Valley Medical CenterInternship, Transitional Year, 2011 - 2012
Stanford University School of MedicineClass of 2011

ASTRO AdvocacyDay Travel Award ASTRO, 2015
American College of Radiation Oncology (ACRO) Travel Award ACRO, 2015
Radiological Society of North America (RSNA) Trainee Research Prize,Medical Student Category RSNA, 2008
International Anesthesia Research Society (IARS) Congress Best of Section Award in Critical Care Medicine & Trauma IARS, 2006
Join now to see all

PubMed

27 citations
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.
Michael F. Gensheimer, Julian C. Hong, Christine N. Chang-Halpenny, Hui Zhu, Neville Eclov
Radiotherapy and Oncology. 2017-08-19
6 citations
Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Christine N. Chang-Halpenny, Sathima Natarajan, Julie Hwang-Graziano
American Journal of Clinical Oncology. 2016-03-04
11 citations
Perspectives of Mobile Versus Fixed Mammography in Santa Clara County, California: A Focus Group Study
Yi-Ren Chen, Christine N. Chang-Halpenny, Narmadan A Kumarasamy, Angela Venegas, Clarence H. Braddock
Cureus. 2016-02-12

Journal Articles

Outcomes of modestly hypofractionated radiation for lung tumors: pre- and mid-treatment positron emission tomography-computed tomography metrics as prognostic factors
Harris J, Chang-Halpenny C, Maxim PG, Quon A, Graves EE, Diehn M, Loo, BW, Clinical Lung Cancer, 1/31/2015
Elderly Patients with Glioblastoma Multiforme Treated with Concurrent Temozolomide and Standard versus Abbreviated Course Radiotherapy
Chang-Halpenny CN, Yeh J, Lien W, The Permanente Journal, 1/1/2015
Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors
Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, Le Q..., Int J Radiat Oncol Biol Phys, 9/1/2012
Gene expression profiling: classification of mice with left ventricle systolic dysfunction using microarray analysis
Wong J, Chang C, Agrawal R, Walton GB, Chen C, Murphy A, Patterson AJ., Critical Care Med, 1/1/2010
Impact of phosphodiesterase 4D on cardiac beta2 adrenergic receptor signaling
Patterson AJ, Pearl N, Chang C, Seminars in Anesthesia, 2007
Join now to see all

Stanford Medical Scholars Research Grants (2 awarded)Stanford Medical SchoolPresent
Stanford Undergraduate Research Major GrantStanford UniversityPresent

Kaiser Permanente Southern California Radiation Oncology, PIs Dr J Hwang, Dr W Lien, Dr J Rahimian, Dr A RaoProjects on GBM, uterine papillary serous carcinoma, uterine clear cell carcinoma, radiosurgery (AVM), treatment planning (radiosurgery technique via VMAT)2012 - Present
Stanford Radiation Oncology, PI Dr Bill LooClinical research on RT, SABR and PET CT for non-small cell lung cancer2008 - 2009
Stanford Department of Anesthesia, PI Dr Andrew PattersonHeart failure and beta-adrenergic receptors, basic science laboratory, full time 2006-2007. Included genotyping, pressure-volume loop calculation, cellular assays.2006 - 2007